» Articles » PMID: 33298184

Pharmacy Response to COVID-19: Lessons Learnt from Canada

Overview
Date 2020 Dec 10
PMID 33298184
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

When the first wave of COVID-19 hit in March 2020, health care professionals across Canada were challenged to quickly and efficiently adapt to change their work practices in these unprecedented times. Pharmacy professionals, being some of the very few front-line health care workers who remained accessible in person for patients, had to rapidly adopt critical changes in their pharmacies to respond in the best interest of their patients and their pharmacy staff. As challenging and demanding as such changes were, they provided pharmacists with invaluable lessons that would be imperative as the country enters a potentially more dangerous second wave. This article seeks to identify and summarize opportunities for improvement in pharmacy as learnt from the pandemic's first wave. Such areas include but are not limited to handling of drug shortage and addressing drug hoarding and stockpiling, providing physical and mental support for staff, timing of flu vaccine and COVID-19 screening/testing, collaboration between different health care sites as well as collaboration with patients and with other health care professionals, telemedicine and willingness to adopt innovative ideas, need for more staff training and more precise research to provide accurate information and finally the need for more organizational and workplace support. Learning from what went well and what did not work in the early stages of the pandemic is integral to ensure pharmacy professionals are better prepared to protect themselves and their patients amidst a second and possibly subsequent waves.

Citing Articles

Perception of Polish pharmacy students on simulation exercise in pharmaceutical care for diabetes-a pilot study.

Plewka B, Waszyk-Nowaczyk M, Cerbin-Koczorowska M, Przymuszala P, Osmalek T BMC Med Educ. 2024; 24(1):283.

PMID: 38486206 PMC: 10941357. DOI: 10.1186/s12909-024-05245-0.


Behind the Counter: Exploring Pharmacists' Stressors and Lessons Learned During the Pandemic in Ontario, Canada.

Zahoor Z, Papadopoulos A, Nowrouzi-Kia B, Ibrahim P, Tadrous M, Gohar B Health Serv Insights. 2023; 16:11786329231169937.

PMID: 37153881 PMC: 10158801. DOI: 10.1177/11786329231169937.


Prescription trends of antiseizure medications before and during the COVID-19 pandemic.

Lavu A, Janzen D, Aboulatta L, Peymani P, Haidar L, Desrochers B Front Neurol. 2023; 14:1135962.

PMID: 37064207 PMC: 10101333. DOI: 10.3389/fneur.2023.1135962.


Canadian Hospital Pharmacists' Perceptions of Workplace Preparedness and Personal Well-Being during the COVID-19 Pandemic.

Yeh P, McGloin R, Gellatly R Can J Hosp Pharm. 2022; 75(4):276-285.

PMID: 36246447 PMC: 9524558. DOI: 10.4212/cjhp.3225.


Increased self-reported pharmacist prescribing during the COVID-19 pandemic: Using the Theoretical Domains Framework to identify barriers and facilitators to prescribing.

Grant A, Rowe L, Kennie-Kaulbach N, Bishop A, Kontak J, Stewart S Res Social Adm Pharm. 2022; 19(1):133-143.

PMID: 36038458 PMC: 9392557. DOI: 10.1016/j.sapharm.2022.08.014.


References
1.
Singer B . COVID-19 and the next influenza season. Sci Adv. 2020; 6(31):eabd0086. PMC: 7399656. DOI: 10.1126/sciadv.abd0086. View

2.
Elbeddini A, Tayefehchamani Y, Yang L . Strategies to conserve salbutamol pressurized metered-dose inhaler stock levels amid COVID-19 drug shortage. Drugs Ther Perspect. 2020; 36(10):451-454. PMC: 7382319. DOI: 10.1007/s40267-020-00759-1. View

3.
Dzierba A, Pedone T, Patel M, Ciolek A, Mehta M, Berger K . Rethinking the Drug Distribution and Medication Management Model: How a New York City Hospital Pharmacy Department Responded to COVID-19. J Am Coll Clin Pharm. 2020; 3(8):1471-1479. PMC: 7436296. DOI: 10.1002/jac5.1316. View

4.
Elbeddini A, Yeats A . Pharmacist intervention amid the coronavirus disease 2019 (COVID-19) pandemic: from direct patient care to telemedicine. J Pharm Policy Pract. 2020; 13:23. PMC: 7251049. DOI: 10.1186/s40545-020-00229-z. View

5.
Elbeddini A, Wen C, Tayefehchamani Y, To A . Mental health issues impacting pharmacists during COVID-19. J Pharm Policy Pract. 2020; 13:46. PMC: 7374072. DOI: 10.1186/s40545-020-00252-0. View